MedTrace Logo

NorMIGS - a Study of Micro-invasive Glaucoma Surgery

NCT05340647 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-11-29

No results posted yet for this study

Summary

NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.

Conditions

Interventions

PROCEDURE

Preserflo microshunt

Implantation of Preserflo microshunt (Santen) to lower intraocular pressure

PROCEDURE

Trabeculectomy

Trabeculectomy surgery to lower intraocular pressure

PROCEDURE

Other MIGS

Other MIGS than Preserflo microshunt (e.g., XEN gel stent, iStent inject) to lower intraocular pressure

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Olav Kristianslund, MD PhD · Department of Ophthalmology, Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-22
Primary Completion
2023-12-31
Completion
2028-06-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05340647 on ClinicalTrials.gov